Method system and device for assessing insulin sensitivity

US2016106918A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016106918-A1
Application numberUS-201514975935-A
CountryUS
Kind codeA1
Filing dateDec 21, 2015
Priority dateJun 25, 2007
Publication dateApr 21, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method and a system for determining insulin sensitivity (IS) is described. In one aspect the method and the system can be implemented by receiving a first parameter corresponding to an insulin dose in a subcutaneous tissue; applying a first kinetic model to obtain a plasma insulin concentration based on the first parameter; receiving a second parameter corresponding to a plasma glucose concentration; determining the insulin sensitivity (IS) based on the plasma insulin concentration and the second parameter.

First claim

Opening claim text (preview).

1 . A method for determining an insulin dose to be administered by an insulin delivery device based on a determined insulin sensitivity (IS), comprising: providing a subcutaneous glucose sensing apparatus, and the insulin dispensing apparatus; and receiving a first parameter corresponding to a first insulin dose value administered by the insulin dispensing apparatus in a subcutaneous tissue; applying a first kinetic model to obtain a plasma insulin concentration based on the first parameter…

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Next steps

Free tools are coming soon. Tell us what you want to track and we'll notify you.

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016106918A1 cover?
A method and a system for determining insulin sensitivity (IS) is described. In one aspect the method and the system can be implemented by receiving a first parameter corresponding to an insulin dose in a subcutaneous tissue; applying a first kinetic model to obtain a plasma insulin concentration based on the first parameter; receiving a second parameter corresponding to a plasma glucose concen…
Who is the assignee on this patent?
Roche Diabetes Care Inc
What technology area does this patent fall under?
Primary CPC classification A61M5/1723. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Apr 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).